世界の1型糖尿病市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Type 1 Diabetes Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5769 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、1型糖尿病のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（速効型インスリンアナログ、長時間作用型インスリンアナログ、プレミックスインスリンアナログ）、用途別市場規模（病院、診断クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・1型糖尿病の市場動向 ・企業の競争状況、市場シェア ・1型糖尿病の種類別市場規模（速効型インスリンアナログ、長時間作用型インスリンアナログ、プレミックスインスリンアナログ） ・1型糖尿病の用途別市場規模（病院、診断クリニック） ・1型糖尿病の北米市場規模2016-2027（アメリカ、カナダ） ・1型糖尿病のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・1型糖尿病のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・1型糖尿病の中南米市場規模2016-2027（メキシコ、ブラジル） ・1型糖尿病の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Bayer、Eli Lilly、BD、Johnson & Johnson、Merck、Pfizer、AstraZeneca、Roche、Smiths Medical、Medtronic） ・結論

Market Analysis and Insights: Global Type 1 Diabetes Market
The global Type 1 Diabetes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Type 1 Diabetes market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Type 1 Diabetes market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Type 1 Diabetes market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Type 1 Diabetes market.

Global Type 1 Diabetes Scope and Market Size
Type 1 Diabetes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Type 1 Diabetes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Rapid Acting Insulin Analogs
Long Acting Insulin Analogs
Premix Insulin Analogs

Segment by Application
Hospitals
Diagnostic clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Bayer
Eli Lilly
BD
Johnson & Johnson
Merck
Pfizer
AstraZeneca
Roche

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type 1 Diabetes Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Rapid Acting Insulin Analogs
1.2.3 Long Acting Insulin Analogs
1.2.4 Premix Insulin Analogs
1.3 Market by Application
1.3.1 Global Type 1 Diabetes Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Type 1 Diabetes Market Perspective (2016-2027)
2.2 Type 1 Diabetes Growth Trends by Regions
2.2.1 Type 1 Diabetes Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Type 1 Diabetes Historic Market Share by Regions (2016-2021)
2.2.3 Type 1 Diabetes Forecasted Market Size by Regions (2022-2027)
2.3 Type 1 Diabetes Industry Dynamic
2.3.1 Type 1 Diabetes Market Trends
2.3.2 Type 1 Diabetes Market Drivers
2.3.3 Type 1 Diabetes Market Challenges
2.3.4 Type 1 Diabetes Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Type 1 Diabetes Players by Revenue
3.1.1 Global Top Type 1 Diabetes Players by Revenue (2016-2021)
3.1.2 Global Type 1 Diabetes Revenue Market Share by Players (2016-2021)
3.2 Global Type 1 Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Type 1 Diabetes Revenue
3.4 Global Type 1 Diabetes Market Concentration Ratio
3.4.1 Global Type 1 Diabetes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type 1 Diabetes Revenue in 2020
3.5 Type 1 Diabetes Key Players Head office and Area Served
3.6 Key Players Type 1 Diabetes Product Solution and Service
3.7 Date of Enter into Type 1 Diabetes Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Type 1 Diabetes Breakdown Data by Type
4.1 Global Type 1 Diabetes Historic Market Size by Type (2016-2021)
4.2 Global Type 1 Diabetes Forecasted Market Size by Type (2022-2027)

5 Type 1 Diabetes Breakdown Data by Application
5.1 Global Type 1 Diabetes Historic Market Size by Application (2016-2021)
5.2 Global Type 1 Diabetes Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Type 1 Diabetes Market Size (2016-2027)
6.2 North America Type 1 Diabetes Market Size by Type
6.2.1 North America Type 1 Diabetes Market Size by Type (2016-2021)
6.2.2 North America Type 1 Diabetes Market Size by Type (2022-2027)
6.2.3 North America Type 1 Diabetes Market Size by Type (2016-2027)
6.3 North America Type 1 Diabetes Market Size by Application
6.3.1 North America Type 1 Diabetes Market Size by Application (2016-2021)
6.3.2 North America Type 1 Diabetes Market Size by Application (2022-2027)
6.3.3 North America Type 1 Diabetes Market Size by Application (2016-2027)
6.4 North America Type 1 Diabetes Market Size by Country
6.4.1 North America Type 1 Diabetes Market Size by Country (2016-2021)
6.4.2 North America Type 1 Diabetes Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Type 1 Diabetes Market Size (2016-2027)
7.2 Europe Type 1 Diabetes Market Size by Type
7.2.1 Europe Type 1 Diabetes Market Size by Type (2016-2021)
7.2.2 Europe Type 1 Diabetes Market Size by Type (2022-2027)
7.2.3 Europe Type 1 Diabetes Market Size by Type (2016-2027)
7.3 Europe Type 1 Diabetes Market Size by Application
7.3.1 Europe Type 1 Diabetes Market Size by Application (2016-2021)
7.3.2 Europe Type 1 Diabetes Market Size by Application (2022-2027)
7.3.3 Europe Type 1 Diabetes Market Size by Application (2016-2027)
7.4 Europe Type 1 Diabetes Market Size by Country
7.4.1 Europe Type 1 Diabetes Market Size by Country (2016-2021)
7.4.2 Europe Type 1 Diabetes Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Type 1 Diabetes Market Size (2016-2027)
8.2 Asia-Pacific Type 1 Diabetes Market Size by Type
8.2.1 Asia-Pacific Type 1 Diabetes Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Type 1 Diabetes Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Type 1 Diabetes Market Size by Type (2016-2027)
8.3 Asia-Pacific Type 1 Diabetes Market Size by Application
8.3.1 Asia-Pacific Type 1 Diabetes Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Type 1 Diabetes Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Type 1 Diabetes Market Size by Application (2016-2027)
8.4 Asia-Pacific Type 1 Diabetes Market Size by Region
8.4.1 Asia-Pacific Type 1 Diabetes Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Type 1 Diabetes Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Type 1 Diabetes Market Size (2016-2027)
9.2 Latin America Type 1 Diabetes Market Size by Type
9.2.1 Latin America Type 1 Diabetes Market Size by Type (2016-2021)
9.2.2 Latin America Type 1 Diabetes Market Size by Type (2022-2027)
9.2.3 Latin America Type 1 Diabetes Market Size by Type (2016-2027)
9.3 Latin America Type 1 Diabetes Market Size by Application
9.3.1 Latin America Type 1 Diabetes Market Size by Application (2016-2021)
9.3.2 Latin America Type 1 Diabetes Market Size by Application (2022-2027)
9.3.3 Latin America Type 1 Diabetes Market Size by Application (2016-2027)
9.4 Latin America Type 1 Diabetes Market Size by Country
9.4.1 Latin America Type 1 Diabetes Market Size by Country (2016-2021)
9.4.2 Latin America Type 1 Diabetes Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Type 1 Diabetes Market Size (2016-2027)
10.2 Middle East & Africa Type 1 Diabetes Market Size by Type
10.2.1 Middle East & Africa Type 1 Diabetes Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Type 1 Diabetes Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Type 1 Diabetes Market Size by Type (2016-2027)
10.3 Middle East & Africa Type 1 Diabetes Market Size by Application
10.3.1 Middle East & Africa Type 1 Diabetes Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Type 1 Diabetes Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Type 1 Diabetes Market Size by Application (2016-2027)
10.4 Middle East & Africa Type 1 Diabetes Market Size by Country
10.4.1 Middle East & Africa Type 1 Diabetes Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Type 1 Diabetes Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Type 1 Diabetes Introduction
11.1.4 Abbott Revenue in Type 1 Diabetes Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Type 1 Diabetes Introduction
11.2.4 Bayer Revenue in Type 1 Diabetes Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Type 1 Diabetes Introduction
11.3.4 Eli Lilly Revenue in Type 1 Diabetes Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Type 1 Diabetes Introduction
11.4.4 BD Revenue in Type 1 Diabetes Business (2016-2021)
11.4.5 BD Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Type 1 Diabetes Introduction
11.5.4 Johnson & Johnson Revenue in Type 1 Diabetes Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Type 1 Diabetes Introduction
11.6.4 Merck Revenue in Type 1 Diabetes Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Type 1 Diabetes Introduction
11.7.4 Pfizer Revenue in Type 1 Diabetes Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Type 1 Diabetes Introduction
11.8.4 AstraZeneca Revenue in Type 1 Diabetes Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Type 1 Diabetes Introduction
11.9.4 Roche Revenue in Type 1 Diabetes Business (2016-2021)
11.9.5 Roche Recent Development
11.10 Smiths Medical
11.10.1 Smiths Medical Company Details
11.10.2 Smiths Medical Business Overview
11.10.3 Smiths Medical Type 1 Diabetes Introduction
11.10.4 Smiths Medical Revenue in Type 1 Diabetes Business (2016-2021)
11.10.5 Smiths Medical Recent Development
11.11 Medtronic
11.11.1 Medtronic Company Details
11.11.2 Medtronic Business Overview
11.11.3 Medtronic Type 1 Diabetes Introduction
11.11.4 Medtronic Revenue in Type 1 Diabetes Business (2016-2021)
11.11.5 Medtronic Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Type 1 Diabetes Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Rapid Acting Insulin Analogs
Table 3. Key Players of Long Acting Insulin Analogs
Table 4. Key Players of Premix Insulin Analogs
Table 5. Global Type 1 Diabetes Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Type 1 Diabetes Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Type 1 Diabetes Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Type 1 Diabetes Market Share by Regions (2016-2021)
Table 9. Global Type 1 Diabetes Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Type 1 Diabetes Market Share by Regions (2022-2027)
Table 11. Type 1 Diabetes Market Trends
Table 12. Type 1 Diabetes Market Drivers
Table 13. Type 1 Diabetes Market Challenges
Table 14. Type 1 Diabetes Market Restraints
Table 15. Global Type 1 Diabetes Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Type 1 Diabetes Market Share by Players (2016-2021)
Table 17. Global Top Type 1 Diabetes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 1 Diabetes as of 2020)
Table 18. Ranking of Global Top Type 1 Diabetes Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Type 1 Diabetes Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Type 1 Diabetes Product Solution and Service
Table 22. Date of Enter into Type 1 Diabetes Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Type 1 Diabetes Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Type 1 Diabetes Revenue Market Share by Type (2016-2021)
Table 26. Global Type 1 Diabetes Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Type 1 Diabetes Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Type 1 Diabetes Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Type 1 Diabetes Revenue Market Share by Application (2016-2021)
Table 30. Global Type 1 Diabetes Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Type 1 Diabetes Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Type 1 Diabetes Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Type 1 Diabetes Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Type 1 Diabetes Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Type 1 Diabetes Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Type 1 Diabetes Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Type 1 Diabetes Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Type 1 Diabetes Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Type 1 Diabetes Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Type 1 Diabetes Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Type 1 Diabetes Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Type 1 Diabetes Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Type 1 Diabetes Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Type 1 Diabetes Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Type 1 Diabetes Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Type 1 Diabetes Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Type 1 Diabetes Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Type 1 Diabetes Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Type 1 Diabetes Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Type 1 Diabetes Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Type 1 Diabetes Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Type 1 Diabetes Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Type 1 Diabetes Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Type 1 Diabetes Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Type 1 Diabetes Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Type 1 Diabetes Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Type 1 Diabetes Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Type 1 Diabetes Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Type 1 Diabetes Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Type 1 Diabetes Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Type 1 Diabetes Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Type 1 Diabetes Product
Table 65. Abbott Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Bayer Company Details
Table 68. Bayer Business Overview
Table 69. Bayer Type 1 Diabetes Product
Table 70. Bayer Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million)
Table 71. Bayer Recent Development
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Type 1 Diabetes Product
Table 75. Eli Lilly Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. BD Company Details
Table 78. BD Business Overview
Table 79. BD Type 1 Diabetes Product
Table 80. BD Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million)
Table 81. BD Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Type 1 Diabetes Product
Table 85. Johnson & Johnson Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Type 1 Diabetes Product
Table 90. Merck Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Type 1 Diabetes Product
Table 95. Pfizer Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. AstraZeneca Company Details
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Roche Company Details
Table 102. Roche Business Overview
Table 103. Roche Type 1 Diabetes Product
Table 104. Roche Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million)
Table 105. Roche Recent Development
Table 106. Smiths Medical Company Details
Table 107. Smiths Medical Business Overview
Table 108. Smiths Medical Type 1 Diabetes Product
Table 109. Smiths Medical Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million)
Table 110. Smiths Medical Recent Development
Table 111. Medtronic Company Details
Table 112. Medtronic Business Overview
Table 113. Medtronic Type 1 Diabetes Product
Table 114. Medtronic Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million)
Table 115. Medtronic Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Type 1 Diabetes Market Share by Type: 2020 VS 2027
Figure 2. Rapid Acting Insulin Analogs Features
Figure 3. Long Acting Insulin Analogs Features
Figure 4. Premix Insulin Analogs Features
Figure 5. Global Type 1 Diabetes Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic clinics Case Studies
Figure 8. Type 1 Diabetes Report Years Considered
Figure 9. Global Type 1 Diabetes Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Type 1 Diabetes Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Type 1 Diabetes Market Share by Regions: 2020 VS 2027
Figure 12. Global Type 1 Diabetes Market Share by Regions (2022-2027)
Figure 13. Global Type 1 Diabetes Market Share by Players in 2020
Figure 14. Global Top Type 1 Diabetes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 1 Diabetes as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Type 1 Diabetes Revenue in 2020
Figure 16. Global Type 1 Diabetes Revenue Market Share by Type (2016-2021)
Figure 17. Global Type 1 Diabetes Revenue Market Share by Type (2022-2027)
Figure 18. North America Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Type 1 Diabetes Market Share by Type (2016-2027)
Figure 20. North America Type 1 Diabetes Market Share by Application (2016-2027)
Figure 21. North America Type 1 Diabetes Market Share by Country (2016-2027)
Figure 22. United States Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Type 1 Diabetes Market Share by Type (2016-2027)
Figure 26. Europe Type 1 Diabetes Market Share by Application (2016-2027)
Figure 27. Europe Type 1 Diabetes Market Share by Country (2016-2027)
Figure 28. Germany Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Type 1 Diabetes Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Type 1 Diabetes Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Type 1 Diabetes Market Share by Region (2016-2027)
Figure 38. China Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Type 1 Diabetes Market Share by Type (2016-2027)
Figure 46. Latin America Type 1 Diabetes Market Share by Application (2016-2027)
Figure 47. Latin America Type 1 Diabetes Market Share by Country (2016-2027)
Figure 48. Mexico Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Type 1 Diabetes Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Type 1 Diabetes Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Type 1 Diabetes Market Share by Country (2016-2027)
Figure 54. Turkey Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Revenue Growth Rate in Type 1 Diabetes Business (2016-2021)
Figure 58. Bayer Revenue Growth Rate in Type 1 Diabetes Business (2016-2021)
Figure 59. Eli Lilly Revenue Growth Rate in Type 1 Diabetes Business (2016-2021)
Figure 60. BD Revenue Growth Rate in Type 1 Diabetes Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Type 1 Diabetes Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Type 1 Diabetes Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Type 1 Diabetes Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Type 1 Diabetes Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Type 1 Diabetes Business (2016-2021)
Figure 66. Smiths Medical Revenue Growth Rate in Type 1 Diabetes Business (2016-2021)
Figure 67. Medtronic Revenue Growth Rate in Type 1 Diabetes Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---